Cencora Inc
COR
查看详细走势图
350.162USD
+4.162+1.20%
交易中 （美东）报价延迟15分钟
67.91B总市值
43.67市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+1.20%
5天
+3.09%
1月
-3.25%
6月
+18.48%
今年开始到现在
+55.85%
1年
+50.78%
查看详细走势图
TradingKey Cencora Inc股票评分
单位: USD 更新时间: 2025-12-12操作建议
Cencora Inc当前公司基本面数据相对稳定，增长潜力很大。当前估值合理，在医疗设备与耗材行业排名30/208位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价384.45。中期看，股价处于上升通道。近一个月，市场表现一般，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Cencora Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
18
位分析师
买入
评级
384.451
目标均价
+13.80%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Cencora Inc亮点
亮点风险
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
行业龙头
公司营业收入处于行业前列，最新年度总收入321.33B美元
业绩高增长
公司营业收入稳步增长，连续3年增长22.56%
高分红
公司属于高分红公司，最新股息支付率28.12%
稳定分红
公司5年内连续分红，最新股息支付率28.12%
估值高估
公司最新PE估值43.15，处于3年历史高位
机构加仓
最新机构持股185.17M股，环比增加0.02%
Mairs and Power 公司持仓
明星投资者Mairs and Power 公司持仓，最新持仓市值1.60K
Cencora Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Cencora Inc简介
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
公司代码COR
公司Cencora Inc
CEOMauch (Robert P)
网址https://www.cencora.com/
常见问题
Cencora Inc(COR)的当前股价是多少？
Cencora Inc(COR)的当前股价是 350.162。
Cencora Inc的股票代码是什么？
Cencora Inc的股票代码是COR。
Cencora Inc股票的52周最高点是多少？
Cencora Inc股票的52周最高点是377.540。
Cencora Inc股票的52周最低点是多少？
Cencora Inc股票的52周最低点是223.920。
Cencora Inc的市值是多少？
Cencora Inc的市值是67.91B。
Cencora Inc的净利润是多少？
Cencora Inc的净利润为1.55B。
现在Cencora Inc(COR)的股票是买入、持有还是卖出？
根据分析师评级，Cencora Inc(COR)的总体评级为买入，目标价格为384.451。
Cencora Inc(COR)股票的每股收益（EPS TTM）是多少
Cencora Inc(COR)股票的每股收益（EPS TTM）是8.019。
相关品种
